Yes, addiction is officially classified as a mental illness. The American Psychiatric Association includes it in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) under the term “substance use disorder,” and the American Society of Addiction Medicine defines it as “a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual’s life experiences.” This dual recognition as both a mental disorder and a chronic medical disease reflects how deeply addiction reshapes the brain.
How Addiction Is Classified in the DSM-5
The DSM-5, published in 2013, replaced the older categories of “substance abuse” and “substance dependence” with a single diagnosis: substance use disorder. This change was based on findings from over 200,000 study participants showing that abuse and dependence weren’t truly separate conditions but points on the same spectrum.
A substance use disorder diagnosis is based on 11 possible criteria. These include things like using more of a substance than intended, unsuccessful attempts to cut back, intense cravings, continued use despite relationship problems or physical harm, and developing tolerance or withdrawal symptoms. Craving was added as a new criterion in the DSM-5, while legal problems were dropped because they didn’t reliably reflect the disorder itself.
The number of criteria you meet determines severity. Two to three criteria indicate a mild substance use disorder, four to five indicate moderate, and six or more indicate severe. This spectrum approach is a significant shift from the older all-or-nothing model, recognizing that addiction exists in degrees rather than as a single threshold you either cross or don’t.
What Happens in the Brain
Addiction changes the brain in measurable, physical ways, which is a core reason it’s classified alongside other mental illnesses. The process unfolds across three interconnected stages, each involving different brain circuits.
During intoxication, drugs hijack the brain’s reward system. The area responsible for registering pleasure and forming habits gets flooded with chemical signals that dwarf what natural rewards like food or social connection produce. Over time, this system recalibrates. Activities that once felt satisfying lose their appeal, while the substance becomes the dominant source of reward. This is why people with addiction often lose interest in hobbies, relationships, and goals they once cared about.
As the disorder progresses, the brain’s stress systems become overactive. When the substance wears off, the result isn’t just a return to normal. It’s a state of heightened anxiety, irritability, and discomfort that drives the urge to use again just to feel okay. Meanwhile, the prefrontal cortex, the region responsible for decision-making, impulse control, and long-term planning, becomes less effective. This creates a painful combination: stronger compulsions paired with a weakened ability to resist them. It’s not a failure of willpower. It’s a brain whose control circuitry has been physically disrupted.
Genetics and Environment Both Matter
Twin and family studies consistently show that genetic factors account for roughly 50% of a person’s risk of developing a substance use disorder. That’s comparable to the genetic contribution seen in conditions like type 2 diabetes or heart disease. No single “addiction gene” has been identified. Instead, hundreds of genetic variations each contribute a small amount of risk, influencing things like how your body metabolizes a substance, how intensely you experience its effects, and how your stress response is wired.
The other half of the equation is environmental. Childhood trauma, chronic stress, early exposure to substances, peer influence, and lack of social support all raise risk. Importantly, genetics and environment interact. Someone with a high genetic predisposition may never develop a problem if they grow up in a stable, low-stress environment. Someone with lower genetic risk may develop one if exposed to severe trauma or early substance use during adolescence, when the brain is still developing.
The Overlap With Other Mental Health Conditions
Addiction rarely exists in isolation. According to a 2024 national survey, approximately 21.2 million adults in the United States had both a mental illness and a substance use disorder at the same time. People with mental illness face a higher risk of developing a substance use disorder, and the reverse is also true: substance use disorders make people more vulnerable to other psychiatric conditions.
The most common co-occurring conditions include anxiety disorders, major depression, bipolar disorder, PTSD, ADHD, and schizophrenia. Sometimes the mental illness comes first, and people use substances to manage symptoms they can’t otherwise control. Sometimes heavy substance use triggers or worsens a psychiatric condition. Often, both disorders reinforce each other in a cycle that makes treating just one of them insufficient.
How Addiction Is Treated as a Medical Condition
Because addiction is classified as a chronic medical disease, treatment follows a similar model to other chronic conditions: ongoing management rather than a one-time cure. For opioid use disorder, the FDA has approved three medications that reduce cravings and withdrawal symptoms, stabilizing brain chemistry enough for people to engage in daily life and longer-term recovery. For alcohol use disorder, medications exist that reduce the rewarding effects of drinking or ease withdrawal.
Medication alone, however, is rarely the full picture. Several behavioral therapies have strong evidence behind them. Cognitive-behavioral therapy helps people identify the thought patterns and situations that trigger use and build new coping strategies. Contingency management uses tangible rewards for meeting treatment goals like producing drug-free test results, which has proven especially effective for stimulant use disorders where no medications are currently approved. Motivational interviewing helps people who are ambivalent about change work through that ambivalence at their own pace rather than being pushed into decisions they’re not ready for.
The most effective treatment plans typically combine medication with behavioral therapy and address co-occurring mental health conditions simultaneously. Relapse rates for addiction are similar to those for other chronic diseases like hypertension and asthma, ranging from 40 to 60 percent. A relapse doesn’t mean treatment failed. It means the treatment plan needs adjustment, the same way a doctor would change a blood pressure medication that stopped working.
Why the Classification Matters
Calling addiction a mental illness isn’t just an academic distinction. It has real consequences for how people are treated, both medically and socially. When addiction is framed as a moral failing or a choice, the response tends to be punishment. When it’s recognized as a diagnosable, treatable medical condition with identifiable brain changes and genetic roots, the response shifts toward evidence-based care.
Insurance coverage, access to medication, legal protections against discrimination, and the design of public health policy all hinge on this classification. The shift from viewing addiction as a character flaw to recognizing it as a chronic brain disorder has been one of the most significant changes in mental health over the past two decades. It doesn’t remove personal responsibility from the recovery process, but it does acknowledge that the playing field isn’t level for everyone, and that effective help exists for those who need it.